Cargando…
Impact of COVID-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases
Autores principales: | Richette, Pascal, Allez, Matthieu, Descamps, Vincent, Perray, Lucas, Pilet, Simon, Latourte, Augustin, Maravic, Milka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Masson SAS on behalf of Société française de rhumatologie.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305295/ https://www.ncbi.nlm.nih.gov/pubmed/34314887 http://dx.doi.org/10.1016/j.jbspin.2021.105253 |
Ejemplares similares
-
Impact de la COVID-19 sur l’initiation des prescriptions des biothérapies dans les maladies inflammatoires chroniques()
por: Richette, Pascal, et al.
Publicado: (2022) -
Impact de la COVID-19 sur les initiations et les renouvellements des biothérapies et traitements synthétiques ciblés en France
por: Richette, P., et al.
Publicado: (2020) -
Artificial intelligence to differentiate asthma from COPD in medico-administrative databases
por: Joumaa, Hassan, et al.
Publicado: (2022) -
Multiple Biologics for Multiple T2 Diseases: A Pharmacoepidemiological Algorithm for Sorting Out Patients by Indication
por: Charriot, Jeremy, et al.
Publicado: (2023) -
Time to Total Knee Arthroplasty after Intra-Articular Hyaluronic Acid or Platelet-Rich Plasma Injections: A Systematic Literature Review and Meta-Analysis
por: Berkani, Sabryne, et al.
Publicado: (2022)